Mortality in glioblastoma multiforme and giant cell glioblastoma

Takeaway

  • There is no statistically significant difference in mortality between glioblastoma multiforme (GBM) and giant cell glioblastoma (GCG), however older age, being female, and non-Hispanic-Latino ethnicity correlates with increased mortality.

Why this matters

  • The identification of several demographic variables that correlate with increased mortality in GBM and GCG may assist clinicians in predicting prognosis.

Want to read more?

Log in or sign up to access all Neurodiem content.

Already have an account? Log In

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.